drugset / Trial / NCT00290758

Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer

NCT00290758 ↗

Phase 2 Completed 126 enrolled National Cancer Institute (NCI)
RandomizedParallel-groupDouble-blindPrevention

Summary

This randomized phase II trial is studying how well genistein works in preventing breast cancer in women at high risk for breast cancer. Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of genistein may prevent breast cancer in women at high risk for breast cancer.

Timeline

Start
2006-01
Primary completion
2009-03
Completion
2009-07

Outcome

Missed primary endpoint

paper did not reduce breast epithelial proliferation, suggesting a lack of efficacy for breast cancer prevention PMID 22307566 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Genistein Other / unclassified — Oral

Indications